Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats

Neuroscience

Volumn 188, Issue , 2011, Pages 148-156

  Okubo, K ^a   Takahashi, T ^a   Sekiguchi, F ^a   Kanaoka, D ^a   Matsunami, M ^a   Ohkubo, T ^b   Yamazaki, J ^b   Fukushima, N ^a   Yoshida, S ^a   Kawabata, A ^a  

^a KINKI UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Chemotherapy; Hydrogen sulfide; Hyperalgesia; Neuropathic pain; T type calcium channel

Indexed keywords

ALPHA AMINO ACID; ANTISENSE OLIGONUCLEOTIDE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL CAV3.1; CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL T TYPE; CYANOALANINE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; MIBEFRADIL; NNC 55 0396; PACLITAXEL; PROPARGYLGLYCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; ENZYME INHIBITION; EVOKED RESPONSE; GENE SILENCING; HUMAN; HUMAN CELL; INTRAPLANTAR DRUG ADMINISTRATION; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BLOTTING, WESTERN; CALCIUM CHANNELS, T-TYPE; CYCLOPROPANES; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; HYDROGEN SULFIDE; HYPERALGESIA; MALE; NAPHTHALENES; NEURALGIA; PACLITAXEL; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR;

EID: 79958767157     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.004     Document Type: Article

References (41)

1. Abe K., Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996, 16:1066-1071.
2. Alessandri-Haber N., Dina O.A., Yeh J.J., Parada C.A., Reichling D.B., Levine J.D. Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J Neurosci 2004, 24:4444-4452.
3. Bennett G.J. Pathophysiology and animal models of cancer-related painful peripheral neuropathy. Oncologist 2010, 15(Suppl 2):9-12.
4. Bezprozvanny I., Tsien R.W. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 1995, 48:540-549.
5. Bourinet E., Alloui A., Monteil A., Barrere C., Couette B., Poirot O., Pages A., McRory J., Snutch T.P., Eschalier A., Nargeot J. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 2005, 24:315-324.
6. Chemin J., Mezghrani A., Bidaud I., Dupasquier S., Marger F., Barrere C., Nargeot J., Lory P. Temperature-dependent modulation of Cav3 T-type calcium channels by protein kinases C and A in mammalian cells. J Biol Chem 2007, 282:32710-32718.
7. Dina O.A., Chen X., Reichling D., Levine J.D. Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience 2001, 108:507-515.
8. Dogrul A., Gardell L.R., Ossipov M.H., Tulunay F.C., Lai J., Porreca F. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 2003, 105:159-168.
9. Dougherty P.M., Cata J.P., Cordella J.V., Burton A., Weng H.R. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004, 109:132-142.
10. Flatters S.J., Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004, 109:150-161.
11. Flatters S.J., Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 2006, 122:245-257.
12. Fukushima O., Nishimura S., Matsunami M., Aoki Y., Nishikawa H., Ishikura H., Kawabata A. Phosphorylation of ERK in the spinal dorsal horn following pancreatic pronociceptive stimuli with proteinase-activated receptor-2 agonists and hydrogen sulfide in rats: evidence for involvement of distinct mechanisms. J Neurosci Res 2010, 88:3198-3205.
13. Hallaq H., Yang Z., Viswanathan P.C., Fukuda K., Shen W., Wang D.W., Wells K.S., Zhou J., Yi J., Murray K.T. Quantitation of protein kinase A-mediated trafficking of cardiac sodium channels in living cells. Cardiovasc Res 2006, 72:250-261.
14. Huang L., Keyser B.M., Tagmose T.M., Hansen J.B., Taylor J.T., Zhuang H., Zhang M., Ragsdale D.S., Li M. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 2004, 309:193-199.
15. Ishii I., Akahoshi N., Yu X.N., Kobayashi Y., Namekata K., Komaki G., Kimura H. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J 2004, 381:113-123.
16. Jagodic M.M., Pathirathna S., Joksovic P.M., Lee W., Nelson M.T., Naik A.K., Su P., Jevtovic-Todorovic V., Todorovic S.M. Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol 2008, 99:3151-3156.
17. Jagodic M.M., Pathirathna S., Nelson M.T., Mancuso S., Joksovic P.M., Rosenberg E.R., Bayliss D.A., Jevtovic-Todorovic V., Todorovic S.M. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 2007, 27:3305-3316.
18. Kaley T.J., Deangelis L.M. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol 2009, 145:3-14.
19. Kawabata A., Ishiki T., Nagasawa K., Yoshida S., Maeda Y., Takahashi T., Sekiguchi F., Wada T., Ichida S., Nishikawa H. Hydrogen sulfide as a novel nociceptive messenger. Pain 2007, 132:74-81.
20. Kimura H. Hydrogen sulfide: from brain to gut. Antioxid Redox Signal 2010, 12:1111-1123.
21. Latham J.R., Pathirathna S., Jagodic M.M., Choe W.J., Levin M.E., Nelson M.T., Lee W.Y., Krishnan K., Covey D.F., Todorovic S.M., Jevtovic-Todorovic V. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 2009, 58:2656-2665.
22. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., Anuar F.B., Whiteman M., Salto-Tellez M., Moore P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005, 19:1196-1198.
23. Li L., Moore P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?. Trends Pharmacol Sci 2008, 29:84-90.
24. Maeda Y., Aoki Y., Sekiguchi F., Matsunami M., Takahashi T., Nishikawa H., Kawabata A. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Pain 2009, 142:127-132.
25. Martin R.L., Lee J.H., Cribbs L.L., Perez-Reyes E., Hanck D.A. Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 2000, 295:302-308.
26. Matsunami M., Tarui T., Mitani K., Nagasawa K., Fukushima O., Okubo K., Yoshida S., Takemura M., Kawabata A. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 2009, 58:751-761.
27. Messinger R.B., Naik A.K., Jagodic M.M., Nelson M.T., Lee W.Y., Choe W.J., Orestes P., Latham J.R., Todorovic S.M., Jevtovic-Todorovic V. In vivo silencing of the Cav3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 2009, 145:184-195.
28. Mok Y.Y., Atan M.S., Yoke Ping C., Zhong Jing W., Bhatia M., Moochhala S., Moore P.K. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 2004, 143:881-889.
29. Nagasawa K., Tarui T., Yoshida S., Sekiguchi F., Matsunami M., Ohi A., Fukami K., Ichida S., Nishikawa H., Kawabata A. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels. J Neurochem 2009, 108:676-684.
30. Nieto F.R., Entrena J.M., Cendan C.M., Pozo E.D., Vela J.M., Baeyens J.M. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain 2008, 137:520-531.
31. Nishimura S., Fukushima O., Ishikura H., Takahashi T., Matsunami M., Tsujiuchi T., Sekiguchi F., Naruse M., Kamanaka Y., Kawabata A. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. Gut 2009, 58:762-770.
32. Ohkubo T., Inoue Y., Kawarabayashi T., Kitamura K. Identification and electrophysiological characteristics of isoforms of T-type calcium channel Cav3.2 expressed in pregnant human uterus. Cell Physiol Biochem 2005, 16:245-254.
33. Polomano R.C., Mannes A.J., Clark U.S., Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001, 94:293-304.
34. Snyder E.M., Colledge M., Crozier R.A., Chen W.S., Scott J.D., Bear M.F. Role for A kinase-anchoring proteins (AKAPS) in glutamate receptor trafficking and long term synaptic depression. J Biol Chem 2005, 280:16962-16968.
35. Takahashi T., Aoki Y., Okubo K., Maeda Y., Sekiguchi F., Mitani K., Nishikawa H., Kawabata A. Upregulation of Cav3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain. Pain 2010, 150:183-191.
36. Taniguchi E., Matsunami M., Kimura T., Yonezawa D., Ishiki T., Sekiguchi F., Nishikawa H., Maeda Y., Ishikura H., Kawabata A. Rhodanese, but not cystathionine-gamma-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: a sign of impaired colonic sulfide detoxification?. Toxicology 2009, 264:96-103.
37. Tarui T., Fukami K., Nagasawa K., Yoshida S., Sekiguchi F., Kawabata A. Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide. J Neurochem 2010, 114:512-519.
38. Vitko I., Bidaud I., Arias J.M., Mezghrani A., Lory P., Perez-Reyes E. The I-II loop controls plasma membrane expression and gating of Cav3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations. J Neurosci 2007, 27:322-330.
39. Yang Z.Q., Barrow J.C., Shipe W.D., Schlegel K.A., Shu Y., Yang F.V., Lindsley C.W., Rittle K.E., Bock M.G., Hartman G.D., Uebele V.N., Nuss C.E., Fox S.V., Kraus R.L., Doran S.M., Connolly T.M., Tang C., Ballard J.E., Kuo Y., Adarayan E.D., Prueksaritanont T., Zrada M.M., Marino M.J., Graufelds V.K., DiLella A.G., Reynolds I.J., Vargas H.M., Bunting P.B., Woltmann R.F., Magee M.M., Koblan K.S., Renger J.J. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels. J Med Chem 2008, 51:6471-6477.
40. Zamponi G.W., Lewis R.J., Todorovic S.M., Arneric S.P., Snutch T.P. Role of voltage-gated calcium channels in ascending pain pathways. Brain Res Rev 2009, 60:84-89.
41. Zhang Y., Helm J.S., Senatore A., Spafford J.D., Kaczmarek L.K., Jonas E.A. PKC-induced intracellular trafficking of Cav2 precedes its rapid recruitment to the plasma membrane. J Neurosci 2008, 28:2601-2612.